000 01666 a2200493 4500
005 20250513134946.0
264 0 _c19980330
008 199803s 0 0 eng d
022 _a1042-8194
024 7 _a10.3109/10428199709058315
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDefard, M
245 0 0 _aComparison of the effects of AcSDKP, thymosin beta4, macrophage inflammatory protein 1alpha and transforming growth factor beta on human leukemic cells.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cNov 1997
300 _a487-94 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBurkitt Lymphoma
_xpathology
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aChemokine CCL4
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aLeukemia, Myeloid, Acute
_xpathology
650 0 4 _aMacrophage Inflammatory Proteins
_xpharmacology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOligopeptides
_xpharmacology
650 0 4 _aThymosin
_xpharmacology
650 0 4 _aTransforming Growth Factor beta
_xpharmacology
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aLemoine, F M
700 1 _aBonnet, M L
700 1 _aBaillou, C
700 1 _aIsnard, F
700 1 _aNajman, A
700 1 _aGuigon, M
773 0 _tLeukemia & lymphoma
_gvol. 27
_gno. 5-6
_gp. 487-94
856 4 0 _uhttps://doi.org/10.3109/10428199709058315
_zAvailable from publisher's website
999 _c9446006
_d9446006